They cannot
And this month it landed in front of the FDA, where an advisory panel voted to make it easier to get overruling the agency's own scientists, who said the evidence simply isn't there [2]
The dry needling group applied 3 sessions of dry needling to the myofascial trigger points in the lower limb muscles
The FDA subsequently classified AOD-9604 within Category 2 of the bulk drug substance review process, and the compound was later withdrawn from that nomination in April 2026
Research in rats shows that the peptide substantially increases the rate of collateral blood vessel growth in the setting of ischemia [4]
Aureli, A., Recupero, R., Mariani, M., Manco, M., Carlomagno, F., Bocchini, S., Nicodemo, M., Marchili, M